Concepedia

Author

Raynier Devillier

Institut Paoli-CalmettesORCID

Also Known As

Devillier R, Devillier Raynier, Devillier, Raynier, Gaspar Aspas Requena, Jan Bewersdorf, Norbert Vey, R Devillier, R. Devillier, Raynier Devillier, Stéphanie Nguyen Quoc

216

Publications

3.2K

Citations

32

H-Index

39

Concepts

All Affiliations

Institut Paoli-CalmettesAix-Marseille UniversitéInsermCentre de Recherche en Cancérologie de MarseilleHumanitas University
RD

About

Raynier Devillier is an author at Institut Paoli-Calmettes specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

28

1.3K

2

Blood Transplantation

13

15

783

3

Health Sciences

10

10

321

4

Cellular Therapies

6

6

136

5

Cell Biology

4

4

190

Raynier Devillier

×

51

Publications

2.3K

Citations

29

H-Index

YearCitations

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori, Laura Zito, Valentina Gambacorta,

Nature Medicine

2019

393

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

Sumin Jo, Shipra Das, Alan F. Williams,

Nature Communications

2022

142

Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor

Didier Blaise, Sabine Fürst, Roberto Crocchiolo,

Biology of Blood and Marrow Transplantation

2015

88

Role of<i>ASXL1</i>and<i>TP53</i>mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

Raynier Devillier, Véronique Mansat‐De Mas, Véronique Gelsi‐Boyer,

Oncotarget

2015

77

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Raynier Devillier, Roberto Crocchiolo, Luca Castagna,

Bone Marrow Transplantation

2012

70

Acute myeloid leukemia with myelodysplasia‐related changes are characterized by a specific molecular pattern with high frequency of <i>ASXL1</i> mutations

Raynier Devillier, Véronique Gelsi‐Boyer, Mandy Brecqueville,

American Journal of Hematology

2012

69

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

Jurjen Versluis, Florentien E. M. in ’t Hout, Raynier Devillier,

Leukemia

2016

65

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

P Bernard, Rebecca B. Delconte, Sonia Pastor,

Journal for ImmunoTherapy of Cancer

2022

62

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hematologic diseases

Roberto Crocchiolo, Benjamin Esterni, Luca Castagna,

Cancer

2012

61

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

Rémy Duléry, Claire Goudet, Daniele Mannina,

Bone Marrow Transplantation

2022

61

Page 1